Further considerations on adverse reactions to radiopharmaceuticals

被引：0
作者：
Massimo Salvatori
Giorgio Treglia
Nadia Mores
机构：
[1] Catholic University of Sacred Heart,Institute of Nuclear Medicine, Policlinico Universitario A.Gemelli
[2] Catholic University of Sacred Heart,Institute of Pharmacology, Pharmacovigilance, Policlinico Universitario A.Gemelli
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2012年 / 39卷
关键词：
Adverse Reaction; Pool Prevalence; Large Longitudinal Study; High Reporting Rate; Italian Medicine Agency;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1360 / 1362
页数：2
相关论文
共 32 条
  • [1] Santos-Oliveira R(2011)Pitfalls with radiopharmaceuticals Am J Med Sci 342 50-53
  • [2] Machado M(1996)Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine J Nucl Med 37 185-192
  • [3] Silberstein EB(1997)Frequency of adverse reactions to radiopharmaceuticals in Europe Eur J Nucl Med 24 1179-1182
  • [4] Ryan J(1998)Prevalence of adverse reactions to positron emitting radiopharmaceuticals in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine J Nucl Med 39 2190-2192
  • [5] Hesslewood SR(2006)The 27th report on survey of the adverse reaction to radiopharmaceuticals (the 30th survey in 2004) Kaku Igaku 43 23-35
  • [6] Keeling DH(2007)The 28th report on survey of the adverse reaction to radiopharmaceuticals (the 31st survey in 2005) Kaku Igaku 44 29-42
  • [7] Silberstein EB(2008)The 29th report on survey of the adverse reaction to radiopharmaceuticals (the 32nd survey in 2006) Kaku Igaku 45 19-35
  • [8] Kusakabe K(2009)The 30th report on survey of the adverse reaction to radiopharmaceuticals (the 33rd survey in 2007) Kaku Igaku 46 29-41
  • [9] Okamura T(2002)European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 2000 Eur J Nucl Med Mol Imaging 29 BP13-BP19
  • [10] Kasagi K(undefined)undefined undefined undefined undefined-undefined
1234